Impact of Multidisciplinary Collaborative Intervention on Isolation Implementation in Prevention and Control of Multi-drug Resistance Infection

[1]  Ying Wang,et al.  Impact of Multidisciplinary Collaborative Intervention on Isolation Implementation in the Prevention and Control of Multidrug Resistance Infection—A Retrospective Study , 2020 .

[2]  D. X,et al.  Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalization. , 2020, The Journal of infection.

[3]  M. Jit,et al.  Antimicrobial Resistance in the Asia Pacific region: a meeting report , 2019, Antimicrobial Resistance & Infection Control.

[4]  Terri D. Link.  Guideline Implementation: Transmission-Based Precautions. , 2019, AORN journal.

[5]  Meilian Chen,et al.  Impact of Healthcare-Associated Infections on Length of Stay: A Study in 68 Hospitals in China , 2019, BioMed research international.

[6]  B. Cookson,et al.  Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey , 2018, Antimicrobial Resistance & Infection Control.

[7]  A. Uhlemann,et al.  Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study , 2017, PloS one.

[8]  P. Vanhems,et al.  Determinants of Implementation of Isolation Precautions Against Infections by Multidrug-Resistant Microorganisms: A Hospital-Based, Multicenter, Observational Study , 2017, Infection Control & Hospital Epidemiology.

[9]  A. Amin,et al.  Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options. , 2016, Microbial drug resistance.

[10]  Dahai Tang,et al.  Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China. , 2016, American journal of infection control.

[11]  A. Durand,et al.  Faut-il isoler les patients porteurs de BMR ? , 2016 .

[12]  R. Khakoo,et al.  Multidisciplinary performance improvement team for reducing health care-associated Clostridium difficile infection. , 2016, American journal of infection control.

[13]  P. Davidson,et al.  Multidisciplinary management of chronic heart failure: principles and future trends. , 2015, Clinical therapeutics.

[14]  Yi Xie,et al.  Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China , 2015, PloS one.

[15]  J. Shang,et al.  Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature , 2015, Journal of Hospital Infection.

[16]  B. Cookson,et al.  ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  Jane D. Single....  Management of Multidrug- resistant organisms in Healthcare settings , 2013 .

[18]  M. D. Kraker,et al.  The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  C. Landelle,et al.  Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? , 2013, Virulence.

[20]  N. Fishman,et al.  Healthcare Infection Control Practices Advisory Committee , 2012 .

[21]  G. Abdulrahman.  The effect of multidisciplinary team care on cancer management , 2011, The Pan African medical journal.

[22]  G. Taylor,et al.  An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective. , 2011, American journal of infection control.

[23]  E. Larson,et al.  Contact precautions for multidrug-resistant organisms: Current recommendations and actual practice. , 2010, American journal of infection control.

[24]  E. Tacconelli,et al.  Screening and isolation for infection control. , 2009, The Journal of hospital infection.

[25]  Philip Smith,et al.  SHEA/APIC Guideline: Infection prevention and control in the long-term care facility , 2008, American Journal of Infection Control.

[26]  M. Jackson,et al.  Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.

[27]  M. Jackson,et al.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.

[28]  Y. Carmeli,et al.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[29]  M. Jackson,et al.  Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. , 2007 .

[30]  Susan Catt,et al.  Multidisciplinary teams in cancer care: are they effective in the UK? , 2006, The Lancet. Oncology.

[31]  B S Cooper,et al.  Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature , 2004, BMJ : British Medical Journal.

[32]  Philip Smith,et al.  Infection Prevention and Control in the Long-Term-Care Facility , 1997, Infection Control & Hospital Epidemiology.

[33]  J. Boyce,et al.  Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus Possible Infection Control Implications , 1997, Infection Control & Hospital Epidemiology.